![Jonathan Dole](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Jonathan Dole is the founder of Endpoint Clinical, Inc. which was founded in 2009.
He is currently working as a Director at Atreo, Inc. since 2023.
Jonathan Dole active positions
Companies | Position | Start |
---|---|---|
Atreo, Inc.
![]() Atreo, Inc. Packaged SoftwareTechnology Services Atreo, Inc. offers modern testing practices for RTSM (Randomization and Trial Supply Management) that provide 10x testing coverage compared to legacy providers. The American company allows clients to preview their RTSM, tailored to their protocol, at bid defense and throughout the system design experience. Ryan Harrison has been the CEO of the company since 2021. | Director/Board Member | 18/07/2023 |
Former positions of Jonathan Dole
Companies | Position | End |
---|---|---|
Endpoint Clinical, Inc.
![]() Endpoint Clinical, Inc. Information Technology ServicesTechnology Services LabCorp Endpoint Clinical, Inc. develops technology platform to support the life sciences industry. The firm have deployed systems to small, medium and large pharma for domestic and global studies. The company was founded by Jonathan Dole and Tom O’Connell in 2009 and is headquartered in San Francisco, CA. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Endpoint Clinical, Inc.
![]() Endpoint Clinical, Inc. Information Technology ServicesTechnology Services LabCorp Endpoint Clinical, Inc. develops technology platform to support the life sciences industry. The firm have deployed systems to small, medium and large pharma for domestic and global studies. The company was founded by Jonathan Dole and Tom O’Connell in 2009 and is headquartered in San Francisco, CA. | Technology Services |
Atreo, Inc.
![]() Atreo, Inc. Packaged SoftwareTechnology Services Atreo, Inc. offers modern testing practices for RTSM (Randomization and Trial Supply Management) that provide 10x testing coverage compared to legacy providers. The American company allows clients to preview their RTSM, tailored to their protocol, at bid defense and throughout the system design experience. Ryan Harrison has been the CEO of the company since 2021. | Technology Services |
- Stock Market
- Insiders
- Jonathan Dole